The Clear Winner for Itchy Skin: Why Second-Generation Antihistamines Outshine the Old Guard First-Generation Drugs

If you’ve ever battled chronic hives - known medically as chronic urticaria - you know how disruptive the itch, irritation, and sleepless nights can be. Antihistamines are usually the first line of defense, but not all antihistamines are created equal. A new large-scale study has now settled a long-running debate: first-generation vs. second-generation antihistamines - which actually works better?

Researchers from an international team led by McMaster University reviewed 211 trials involving more than 22,000 participants. Their findings, published in The Journal of Allergy and Clinical Immunology in February 2026, reveal that second-generation antihistamines (like cetirizine, loratadine, and fexofenadine) perform slightly better at taming symptoms - and they do it without making people sleepy.

Key insights:

Better symptom control: Second-generation antihistamines improved overall hive activity for about 10 more patients out of every 100 compared with first-generation drugs.

Improved sleep: People taking newer antihistamines were 20% more likely to report better sleep.

Major difference - sedation: Older medications (like diphenhydramine and hydroxyzine) caused significantly more drowsiness - about 21 more people per 100 felt sedated compared to those on newer drugs.

In short, while both generations can help relieve itching, the evidence strongly supports reaching for second-generation options first. They’re safer for daily use, less sedating, and may even provide a bit more relief. For anyone dealing with chronic hives, this marks another step toward clearer skin - and clearer days.

References:

https://www.sciencedirect.com/science/article/pii/S0091674925012795